Adipose Tissue Distribution and Quantification of PPARβ/δ and PPARγ1-3 mRNAs: Discordant Gene Expression in Subcutaneous, Retroperitoneal and Visceral Adipose Tissue of Morbidly Obese Patients
- 27 July 2007
- journal article
- Published by Springer Nature in Obesity Surgery
- Vol. 17 (7) , 934-940
Abstract
Adipose tissue (AT) metabolism is altered in obese subjects, and the reestablishment of energy homeostasis requires the identification and regulation of genes with altered patterns. The aim of this study was to compare mRNA expression of PPARβ/δ and PPARγ1-3 in morbidly obese and nonobese patients. The expression pattern of these receptors in various abdominal adipose tissues, subcutaneous (SAT), retroperitoneal (RAT) and visceral (VAT), was also evaluated. The AT depots were obtained by surgery. Total RNAs were extracted using TRIzol. PPARs reverse transcripts were determined by quantitative polymerase chain reaction (qRT-PCR). The amounts of PPARβ/δ mRNA in different depots of morbidly obese AT showed a significant decrease in VAT (P < 0.05). In the non-obese group, the level of PPARβ/δ was higher in SAT (P < 0.05), but PPARγ1-3 was not differentially expressed in obese and non-obese depots. When comparing obese and non-obese, the results revealed a decrease in PPARβ/δ expression in SAT (P = 0.058) and VAT (P = 0.094) of the morbidly obese. PPARγ1-3 mRNA expression was increased significantly in SAT (P = 0.022) and decreased in RAT (P = 0.034) in morbidly obese subjects. PPARβ/δ expression in SAT and VAT correlated negatively with hip size and insulin serum respectively. PPARγ1-3 expression in RAT correlated negatively with waist and hip circumference and in VAT correlated positively with waist size. The present study demonstrates that PPARβ/δ and PPARγ1-3 mRNAs are quantitatively different in AT of morbidly obese individuals compared to non-obese, and that PPARβ/δ mRNA levels are characteristic for each AT depot.Keywords
This publication has 32 references indexed in Scilit:
- Peroxisome proliferator-activated receptor δ (PPARδ), a novel target site for drug discovery in metabolic syndromePharmacological Research, 2006
- PPAR : a dagger in the heart of the metabolic syndromeJournal of Clinical Investigation, 2006
- Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetesActa Physiologica, 2006
- Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genesDiabetologia, 2005
- Comparison of Gene Expression in Intra‐Abdominal and Subcutaneous Fat: A Study of Men with Morbid Obesity and Nonobese Men Using Microarray and ProteomicsAnnals of the New York Academy of Sciences, 2004
- Adiponectin, the missing link in insulin resistance and obesityClinical Nutrition, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Leptin, Peroxisome Proliferator-Activated Receptor-γ, and CCAAT/Enhancer Binding Protein-α mRNA Expression in Adipose Tissue of Humans and Their Relation to Cardiovascular Risk FactorsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- PPARγ Activation Induces the Expression of the Adipocyte Fatty Acid Binding Protein Gene in Human MonocytesBiochemical and Biophysical Research Communications, 1999
- Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.Journal of Clinical Investigation, 1997